Growth Metrics

Onconetix (ONCO) Enterprise Value (2023 - 2025)

Historic Enterprise Value for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$836556.0.

  • Onconetix's Enterprise Value fell 11235.81% to -$836556.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$836556.0, marking a year-over-year decrease of 11235.81%. This contributed to the annual value of -$646500.0 for FY2024, which is 12636.44% down from last year.
  • Onconetix's Enterprise Value amounted to -$836556.0 in Q3 2025, which was down 11235.81% from -$300000.0 recorded in Q2 2025.
  • Over the past 5 years, Onconetix's Enterprise Value peaked at $6.8 million during Q3 2024, and registered a low of -$22.3 million during Q1 2023.
  • For the 3-year period, Onconetix's Enterprise Value averaged around -$2.2 million, with its median value being -$646500.0 (2024).
  • In the last 5 years, Onconetix's Enterprise Value skyrocketed by 18844.14% in 2024 and then tumbled by 16222.25% in 2025.
  • Onconetix's Enterprise Value (Quarter) stood at $2.5 million in 2023, then plummeted by 126.36% to -$646500.0 in 2024, then dropped by 29.4% to -$836556.0 in 2025.
  • Its last three reported values are -$836556.0 in Q3 2025, -$300000.0 for Q2 2025, and -$1.6 million during Q1 2025.